Page last updated: 2024-12-05

2-tert-butylhydroquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-tert-Butylhydroquinone (TBHQ) is a synthetic antioxidant commonly used as a food additive to prevent rancidity in fats and oils. It is produced by the alkylation of hydroquinone with tert-butanol. TBHQ is a potent antioxidant that effectively scavenges free radicals, thereby inhibiting oxidation processes. Its effectiveness in preserving the quality and extending the shelf life of food products makes it a valuable additive in the food industry. However, concerns regarding its potential health effects, including possible links to cancer and neurotoxicity, have led to ongoing research into its safety and long-term impacts. TBHQ is also used in various industrial applications, such as rubber and plastics manufacturing, and its potential environmental effects are also being investigated.'

2-tert-butylhydroquinone: an anticarcinogenic and chemopreventive agent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-tert-butylhydroquinone : A member of the class of hydroquinones in which one of the ring hydrogens of hydroquinone is replaced by a tert-butyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID16043
CHEMBL ID242080
CHEBI ID78886
SCHEMBL ID26745
MeSH IDM0070836

Synonyms (138)

Synonym
EYK ,
nsc-4972
tert-butylhydroquinone
nsc4972 ,
tbhq
wln: qr dq bx1&1&1
mono-tert-butylhydroquinone
2-tert-butylhydroquinone
mtbhq
hydroquinone, tert-butyl-
t-butylhydroquinone
1948-33-0
mono-tertiarybutylhydroquinone
2-tert-butyl-1,4-benzenediol
tert-butyl-1,4-benzenediol
NCI60_004196
butylhydroquinone, t-
nsc 4972
monotertiary butyl hydroquinone
sustane
hydroquinone, t-butyl-
2-(1,1-dimethylethyl)benzene-1,4-diol
2-tertiary-butylhydroquinone
t-butyl hydroquinone
brn 0637923
einecs 217-752-2
ai3-61039
2-tert-butyl(1,4)hydroquinone
ccris 1447
2-tert-butylbenzene-1,4-diol
tertiary-butylhydroquinone
2-(1,1-dimethylethyl)-1,4-benzenediol
banox 20ba
2-t-butylhydroquinone
tenox tbhq
1,4-benzenediol (1,1-dimethylethyl)-
hsdb 838
butylhydroquinone, tert-
1,4-benzenediol, 2-(1,1-dimethylethyl)-
tert-butyl hydroquinone
t-bhq
NCGC00013051
NCGC00090788-02
NCGC00090788-01
STK372011
tert-butylhydroquinone, 97%
NCI4972
NCGC00090788-04
NCISTRUC2_000017
NCISTRUC1_000241
NCGC00090788-03
AC-10579
B0833
MLS002222348
smr001253806
2-t-butyl-1,4-benzenediol
DB07726
chebi:78886 ,
CHEMBL242080
e319
2-(tert-butyl)benzene-1,4-diol
FT-0652102
bdbm50065387
NCGC00013051-05
AKOS003627061
tertiary butylhydroquinone
tert-butylhydrochinone
c12674942b ,
ec 217-752-2
unii-c12674942b
NCGC00254178-01
NCGC00259858-01
tox21_300081
tox21_202309
dtxsid6020220 ,
NCGC00013051-01
cas-1948-33-0
dtxcid60220
tox21_110007
tox21_110006
CCG-37948
NCGC00013051-08
NCGC00013051-07
NCGC00013051-06
NCGC00013051-02
NCGC00013051-09
NCGC00013051-04
NCGC00013051-03
KUC109743N
BRD-K36452089-001-01-8
ksc-241-078-1
BRD-K36452089-001-02-6
ins no.319
butylhydroquinone,tert-
hydroquinone,tertiary butyl [vandf]
tertiary butylhydroquinone [mart.]
tert-butylhydroquinone [ii]
hydroquinone,tertiary butyl
t-butylhydroquinone [hsdb]
ins-319
e-319
tbhq [fcc]
tbhq [inci]
S4990
SCHEMBL26745
2-tert-butyl-1,4-dihydroxybenzene
tert.-butyl hydroquinone
2-tert-butyl-hydroquinone
tert-butyl-hydroquinone
1,4-dihydroxy-2-tert-butylbenzene
2-t-butyl hydroquinone
NCGC00013051-10
W-107698
eastman mtbhq
mfcd00002344
tenox 20
2-(tert-butyl)-p-hydroquinone
CS-5774
HY-100489
tert-butylhydroquinone, analytical standard
D70420
sustane tbhq
2-(1,1-dimethylethyl)-1,4-benzenediol, 9ci
tenox tbho
tenox tbhqtbhq
t-butyl-hydroquinone
F0001-0696
2-(tert-butyl)benzene-1,4-diol(may occur to produce black solid)
BS-15862
Q662443
EN300-120878
SY001798
Z1255402624
tertiary butylhydroquinone (mart.)
tert-butylhydroquinone (ii)
2-(1,1-dimethylethyl)hydroquinone
2-tert-butyl-1,4-hydroquinone
thbq

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Since evidence for both oxidative damage and the involvement for glutathione in the toxicity of butylated hydroxyanisole is available, this mechanism may be involved in the toxic action of this compound."( The glutathione conjugates of tert-butyl hydroquinone as potent redox cycling agents and possible reactive agents underlying the toxicity of butylated hydroxyanisole.
Koster, A; van Bladeren, PJ; van Ommen, B; Verhagen, H, 1992
)
0.28
" In contrast, treatment with the quinone reductase inhibitor dicumarol potentiated the toxic effect of glutamate."( Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress.
Coyle, JT; De Long, MJ; Murphy, TH, 1991
)
0.28
" By a single dose of oral administration, DTBHQ-induced LD50 values (obtained by Lorke method) in male and female rats were estimated 295."( [Comparative studies on a single dose toxicity of microsomal Ca(2+)ATPase inhibitor, 2,5-di(tert-butyl)-1,4-hydroquinone and its related analog, mono(tert-butyl)-1,4-hydroquinone, in rats].
Eshita, N; Inoue, T; Kaniwa, M; Kawashima, K; Kitajima, S; Kurokawa, Y; Matsushima, Y; Momma, J; Saitoh, M; Tsuda, M, 1995
)
0.29
" However, the use of BHA as a chemopreventive agent against cancer in human has been challenged by the observation that BHA may exert toxic effect in some tissues of animals."( Molecular mechanisms of butylated hydroxylanisole-induced toxicity: induction of apoptosis through direct release of cytochrome c.
Kong, AN; Mandlekar, S; Yu, R, 2000
)
0.31
" The current work lays the groundwork for using Nrf2 activators for therapeutic and dietary interventions against adverse effects of arsenic."( Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity.
Chen, W; Eblin, KE; Gandolfi, JA; Sun, Z; Wang, XJ; Zhang, DD, 2007
)
0.34
" Death of the seemingly untreated neighboring cells was caused by the more toxic and volatile tBHQ oxidation product tert-butyl-p-benzoquinone (tBQ) present at up to 3 μg/ml in the untreated neighboring wells."( Paradoxical cytotoxicity of tert-butylhydroquinone in vitro: What kills the untreated cells?
Braeuning, A; Orsetti, S; Schwarz, M; Vetter, S, 2012
)
0.38
" Both TBQ and TBE are cytotoxic, but their toxic mechanisms have not been fully characterized."( Protective roles of aldo-keto reductase 1B10 and autophagy against toxicity induced by p-quinone metabolites of tert-butylhydroquinone in lung cancer A549 cells.
Bunai, Y; Chen, H; El-Kabbani, O; Endo, S; Hara, A; Ikari, A; Matsunaga, T; Nishiyama, A; Soda, M; Suyama, M; Tajima, K; Takemura, M, 2015
)
0.42
" The study of acute oral toxicity in mice revealed no adverse short-term effects of consumption in the synthesized materials with non-toxicity evidence until 2000 mg/kg through an oral acute administration."( Suppression of the tert-butylhydroquinone toxicity by its grafting onto chitosan and further cross-linking to agavin toward a novel antioxidant and prebiotic material.
Gimeno, M; Gracia-Mora, I; Hernández-Castro, R; Hernández-Valdepeña, MA; Montiel, C; Nieto-Sotelo, J; Pedraza-Chaverri, J; Sánchez-Bartez, F; Shirai, K, 2016
)
0.43
"Epidemiological studies have demonstrated an association between ambient particulate pollution and adverse health effects in humans."( Using Nrf2/antioxidant response element-dependent signaling to assess the toxicity potential of fly ash particles.
Chen, Y; Tang, X; Wang, H; Wang, XJ; Zhang, J, 2019
)
0.51
" Since molecules that modify redox state have been proven to prevent cellular damage by inducing a hormetic response, the aim of this study was to evaluate if tert-butylhydroquinone (tBHQ) could activate an antioxidant hormetic response that would be able to protect L6 myoblasts from palmitate toxic effect."( tBHQ Induces a Hormetic Response That Protects L6 Myoblasts against the Toxic Effect of Palmitate.
Gómez-Quiroz, LE; González-Puertos, VY; Königsberg, M; Luna-López, A; Posadas-Rodríguez, NE; Posadas-Rodríguez, P; Toledo-Pérez, R; Ventura-Gallegos, JL; Zentella, A, 2020
)
0.56
" It has adverse effects such as apoptosis and breakdown of the blood-brain barrier."( TBHQ-Overview of Multiple Mechanisms against Oxidative Stress for Attenuating Methamphetamine-Induced Neurotoxicity.
Liu, L; Liu, M; Wang, Y; Zhao, W; Zhao, YL, 2020
)
0.56

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" A positive dose-response effect in the SCE frequency was observed using the Cochran-Armitage trend test."( Sister chromatid exchanges induced by tertiary butyl hydroquinone in bone marrow cells of mice.
Mukherjee, A; Sharma, A; Talukder, G, 1989
)
0.28
" Four chemicals, using three different routes of exposure (in utero [accomplished by feeding the dam dosed feed], dosed feed, and gavage) were used to 1) evaluate the effect of diet restriction on the sensitivity of the bioassay toward chemically-induced chronic toxicity and carcinogenicity; and 2) evaluate the effect of weight-matched control groups on the sensitivity of the bioassays."( The sensitivity of the NTP bioassay for carcinogen hazard evaluation can be modulated by dietary restriction.
Abdo, KM; Kari, FW, 1996
)
0.29
" Groups of five males and five females were dosed with TBHQ, HQ, or the vehicle (hydrophilic ointment) daily (M-F) for 13 weeks."( Depigmentation with tert-butyl hydroquinone using black guinea pigs.
Juberg, DR; Maibach, HI; O'Donoghue, J; Patrick, E,
)
0.13
" Using an extracted ion chromatogram (EIC) of m/z 149, free TBHQ was observed in rat serum after dosing TBHQ at 350 mg/kg to male and female Sprague-Dawley (SD) rats."( Determination of tertiary-butylhydroquinone and its metabolites in rat serum by liquid chromatography-ion trap mass spectrometry.
Gu, Y; Huang, W; Niu, H, 2008
)
0.35
" These mathematical relationships can now be applied to individualized EPA dosing in clinical trials."( Biomarkers for personalizing omega-3 fatty acid dosing.
Brenner, DE; Djuric, Z; Hong, YH; Jiang, Y; Kuklev, D; Murphy, RC; Normolle, DP; Ren, J; Sen, A; Smith, WL; Uhlson, CL; Waters, I; Zhao, L, 2014
)
0.4
" All test materials and controls were dosed orally by gavage."( p-Chloroaniline, t-butylhydroquinone, and methyl carbamate: Rat in vivo comet test, JaCVAM trial phase 4.2.
Barfield, W; Burlinson, B, 2015
)
0.42
" The SPR analysis showed dose-response sensograms of BSA upon increasing concentration of PG and TBHQ."( Kinetic studies of bovine serum albumin interaction with PG and TBHQ using surface plasmon resonance.
Ezzati Nazhad Dolatanbadi, J; Fathi, F; Omidi, Y; Rashidi, MR, 2016
)
0.43
"Activation of NRF2 using MMF, at least at our dosing regimen, is insufficient to attenuate catastrophic photoreceptor damage characteristic of rd10 mice."( Comparison of Neuroprotective Effects of Monomethylfumarate to the Sigma 1 Receptor Ligand (+)-Pentazocine in a Murine Model of Retinitis Pigmentosa.
Saul, A; Smith, SB; Wang, J; Xiao, H, 2020
)
0.56
" Intraperitoneal injections of METH at a dose of 10 mg/kg were administered to the rats in the METH and METH+TBHQ groups for one week, and METH was then administered at a dose that increased by 1 mg/kg per week until the sixth week, when the daily dosage reached 15 mg/kg."( TBHQ Attenuates Neurotoxicity Induced by Methamphetamine in the VTA through the Nrf2/HO-1 and PI3K/AKT Signaling Pathways.
Chu, H; Guo, Y; Han, Y; Kong, L; Ma, H; Meng, X; Wang, C; Zhang, C, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
food antioxidantAn antioxidant that used as a food additives to help guard against food deterioration.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydroquinonesBenzenediols that have the hydroxy substituents in the 1- and 4-positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (61)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.50120.003245.467312,589.2998AID2517
Chain A, HADH2 proteinHomo sapiens (human)Potency15.37920.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency15.37920.025120.237639.8107AID886; AID893
LuciferasePhotinus pyralis (common eastern firefly)Potency53.55260.007215.758889.3584AID1224835; AID624030
interleukin 8Homo sapiens (human)Potency66.82420.047349.480674.9780AID651758
acetylcholinesteraseHomo sapiens (human)Potency63.47070.002541.796015,848.9004AID1347395; AID1347398
15-lipoxygenase, partialHomo sapiens (human)Potency11.55750.012610.691788.5700AID887
phosphopantetheinyl transferaseBacillus subtilisPotency22.71700.141337.9142100.0000AID1490
RAR-related orphan receptor gammaMus musculus (house mouse)Potency22.04350.006038.004119,952.5996AID1159521; AID1159523
USP1 protein, partialHomo sapiens (human)Potency39.81070.031637.5844354.8130AID504865
GLS proteinHomo sapiens (human)Potency22.38720.35487.935539.8107AID624170
TDP1 proteinHomo sapiens (human)Potency16.55530.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency8.01500.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency32.88020.000221.22318,912.5098AID588515; AID743035; AID743042; AID743053; AID743054; AID743063
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency1.87430.011212.4002100.0000AID1030
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency47.22100.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency49.59370.001022.650876.6163AID1224838; AID1224839; AID1224893
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency11.05570.01237.983543.2770AID1346984; AID1645841
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency33.20750.000214.376460.0339AID588533; AID720691; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency56.73710.003041.611522,387.1992AID1159552; AID1159553
retinoid X nuclear receptor alphaHomo sapiens (human)Potency32.36300.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency33.24690.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849
pregnane X nuclear receptorHomo sapiens (human)Potency33.10220.005428.02631,258.9301AID1346982; AID1346985; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency29.61790.000229.305416,493.5996AID1259244; AID1259383; AID588513; AID588514; AID743069; AID743075; AID743078; AID743079
GVesicular stomatitis virusPotency11.98770.01238.964839.8107AID1645842
cytochrome P450 2D6Homo sapiens (human)Potency16.93300.00108.379861.1304AID1645840
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency31.58500.001024.504861.6448AID588534; AID588535; AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency35.29210.001019.414170.9645AID588536; AID588537; AID743094; AID743140; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency43.70290.023723.228263.5986AID588541; AID743223; AID743241
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency4.46680.035520.977089.1251AID504332
aryl hydrocarbon receptorHomo sapiens (human)Potency24.75750.000723.06741,258.9301AID651777; AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency40.54300.001723.839378.1014AID743083
activating transcription factor 6Homo sapiens (human)Potency43.64120.143427.612159.8106AID1159516
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency1.230019.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency50.27000.057821.109761.2679AID1159526
Histone H2A.xCricetulus griseus (Chinese hamster)Potency87.55750.039147.5451146.8240AID1224845; AID1224896
cytochrome P450 2C9 precursorHomo sapiens (human)Potency7.94330.00636.904339.8107AID883
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency50.11870.354828.065989.1251AID504847
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency43.42280.010039.53711,122.0200AID588545; AID588547
potassium voltage-gated channel subfamily H member 2 isoform dHomo sapiens (human)Potency28.18380.01789.637444.6684AID588834
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency32.75870.000323.4451159.6830AID743065; AID743066; AID743067
heat shock protein beta-1Homo sapiens (human)Potency61.64480.042027.378961.6448AID743210
huntingtin isoform 2Homo sapiens (human)Potency25.11890.000618.41981,122.0200AID1688
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency20.73190.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency14.83170.00798.23321,122.0200AID2546; AID2551
gemininHomo sapiens (human)Potency14.70420.004611.374133.4983AID624296; AID624297
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency15.70500.005612.367736.1254AID624032; AID624044
lethal factor (plasmid)Bacillus anthracis str. A2012Potency1.00000.020010.786931.6228AID912
lamin isoform A-delta10Homo sapiens (human)Potency1.25890.891312.067628.1838AID1487
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency4.85580.001557.789015,848.9004AID1259244
Interferon betaHomo sapiens (human)Potency11.98770.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency11.98770.01238.964839.8107AID1645842
Cellular tumor antigen p53Homo sapiens (human)Potency20.43510.002319.595674.0614AID651631; AID720552
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency4.85580.001551.739315,848.9004AID1259244
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency7.94330.00638.235039.8107AID883
Nuclear receptor ROR-gammaHomo sapiens (human)Potency23.31740.026622.448266.8242AID651802
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency11.98770.01238.964839.8107AID1645842
cytochrome P450 2C9, partialHomo sapiens (human)Potency11.98770.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TyrosinaseHomo sapiens (human)IC50 (µMol)54.20000.02304.459310.0000AID1193294
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Nuclear receptor subfamily 1 group I member 2Homo sapiens (human)EC50 (µMol)7.30000.00203.519610.0000AID1215086; AID1215087
Nuclear factor erythroid 2-related factor 2Homo sapiens (human)EC50 (µMol)91.53000.06002.61679.9000AID773885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Nuclear factor erythroid 2-related factor 2Homo sapiens (human)Activity2.08170.82001.82095.2700AID1420758; AID1420759; AID1420760; AID1420763; AID1420764; AID1420765
Nuclear factor erythroid 2-related factor 2Homo sapiens (human)CD1.68000.54001.15331.6800AID1686269
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (230)

Processvia Protein(s)Taxonomy
negative regulation of DNA-templated transcriptionNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
regulation of DNA-templated transcriptionNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
xenobiotic metabolic processNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
signal transductionNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
steroid metabolic processNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
positive regulation of gene expressionNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
xenobiotic catabolic processNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
xenobiotic transportNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IINuclear receptor subfamily 1 group I member 2Homo sapiens (human)
cell differentiationNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor subfamily 1 group I member 2Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
melanin biosynthetic process from tyrosineTyrosinaseHomo sapiens (human)
eye pigment biosynthetic processTyrosinaseHomo sapiens (human)
visual perceptionTyrosinaseHomo sapiens (human)
cell population proliferationTyrosinaseHomo sapiens (human)
response to UVTyrosinaseHomo sapiens (human)
response to blue lightTyrosinaseHomo sapiens (human)
response to vitamin DTyrosinaseHomo sapiens (human)
melanin biosynthetic processTyrosinaseHomo sapiens (human)
thymus developmentTyrosinaseHomo sapiens (human)
response to cAMPTyrosinaseHomo sapiens (human)
pigmentationTyrosinaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
response to ischemiaNuclear factor erythroid 2-related factor 2Homo sapiens (human)
regulation of transcription by RNA polymerase IINuclear factor erythroid 2-related factor 2Homo sapiens (human)
inflammatory responseNuclear factor erythroid 2-related factor 2Homo sapiens (human)
response to oxidative stressNuclear factor erythroid 2-related factor 2Homo sapiens (human)
proteasomal ubiquitin-independent protein catabolic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of gene expressionNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of cardiac muscle cell apoptotic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of neuron projection developmentNuclear factor erythroid 2-related factor 2Homo sapiens (human)
protein ubiquitinationNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of blood coagulationNuclear factor erythroid 2-related factor 2Homo sapiens (human)
endoplasmic reticulum unfolded protein responseNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to oxidative stressNuclear factor erythroid 2-related factor 2Homo sapiens (human)
PERK-mediated unfolded protein responseNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to glucose starvationNuclear factor erythroid 2-related factor 2Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationNuclear factor erythroid 2-related factor 2Homo sapiens (human)
regulation of innate immune responseNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cell redox homeostasisNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of angiogenesisNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IINuclear factor erythroid 2-related factor 2Homo sapiens (human)
regulation of embryonic developmentNuclear factor erythroid 2-related factor 2Homo sapiens (human)
aflatoxin catabolic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of glucose importNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to hydrogen peroxideNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to copper ionNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to tumor necrosis factorNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to hypoxiaNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to xenobiotic stimulusNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to fluid shear stressNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to laminar fluid shear stressNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of ferroptosisNuclear factor erythroid 2-related factor 2Homo sapiens (human)
integrated stress response signalingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of cellular response to hypoxiaNuclear factor erythroid 2-related factor 2Homo sapiens (human)
regulation of cellular response to oxidative stressNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of hematopoietic stem cell differentiationNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathwayNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of glutathione biosynthetic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of ERAD pathwayNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cellular response to angiotensinNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of vascular associated smooth muscle cell migrationNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of ubiquitin-dependent protein catabolic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
regulation of removal of superoxide radicalsNuclear factor erythroid 2-related factor 2Homo sapiens (human)
negative regulation of endothelial cell apoptotic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processNuclear factor erythroid 2-related factor 2Homo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (62)

Processvia Protein(s)Taxonomy
RNA polymerase II transcription regulatory region sequence-specific DNA bindingNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
nuclear receptor activityNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
protein bindingNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
zinc ion bindingNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
nuclear receptor bindingNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
tyrosinase activityTyrosinaseHomo sapiens (human)
copper ion bindingTyrosinaseHomo sapiens (human)
protein bindingTyrosinaseHomo sapiens (human)
identical protein bindingTyrosinaseHomo sapiens (human)
protein homodimerization activityTyrosinaseHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
transcription cis-regulatory region bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear factor erythroid 2-related factor 2Homo sapiens (human)
transcription coregulator bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificNuclear factor erythroid 2-related factor 2Homo sapiens (human)
DNA bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
DNA-binding transcription factor activityNuclear factor erythroid 2-related factor 2Homo sapiens (human)
protein bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
protein domain specific bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
ubiquitin protein ligase bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
sequence-specific DNA bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
molecular condensate scaffold activityNuclear factor erythroid 2-related factor 2Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear factor erythroid 2-related factor 2Homo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (47)

Processvia Protein(s)Taxonomy
nucleoplasmNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
transcription regulator complexNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
nuclear bodyNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
intermediate filament cytoskeletonNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
chromatinNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
nucleusNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
cytoplasmTyrosinaseHomo sapiens (human)
lysosomeTyrosinaseHomo sapiens (human)
Golgi-associated vesicleTyrosinaseHomo sapiens (human)
melanosome membraneTyrosinaseHomo sapiens (human)
melanosomeTyrosinaseHomo sapiens (human)
intracellular membrane-bounded organelleTyrosinaseHomo sapiens (human)
perinuclear region of cytoplasmTyrosinaseHomo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
mediator complexNuclear factor erythroid 2-related factor 2Homo sapiens (human)
non-membrane-bounded organelleNuclear factor erythroid 2-related factor 2Homo sapiens (human)
nucleusNuclear factor erythroid 2-related factor 2Homo sapiens (human)
nucleoplasmNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cytoplasmNuclear factor erythroid 2-related factor 2Homo sapiens (human)
Golgi apparatusNuclear factor erythroid 2-related factor 2Homo sapiens (human)
centrosomeNuclear factor erythroid 2-related factor 2Homo sapiens (human)
cytosolNuclear factor erythroid 2-related factor 2Homo sapiens (human)
plasma membraneNuclear factor erythroid 2-related factor 2Homo sapiens (human)
RNA polymerase II transcription regulator complexNuclear factor erythroid 2-related factor 2Homo sapiens (human)
chromatinNuclear factor erythroid 2-related factor 2Homo sapiens (human)
protein-DNA complexNuclear factor erythroid 2-related factor 2Homo sapiens (human)
nucleusNuclear factor erythroid 2-related factor 2Homo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (149)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1285393Induction of quinone reductase specific activity in mouse Hepa1c1c7 cells assessed as concentration required to double enzyme specific activity using 2,6-DCIP as substrate measured for 1 min2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID1420780Hepatoprotective activity against APAP-induced cell injury in human LO2 cells assessed as increase in cell viability at 20 uM pretreated for 24 hrs followed by APAP treatment measured after 24 hrs by MTT assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury.
AID1466122Activation of Nrf2 in human HepG2 cells assessed as increase in GCLM expression level at 20 uM by Western blot analysis2017European journal of medicinal chemistry, Jul-07, Volume: 134Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death.
AID755682Antioxidant activity assessed as hydroxyl radical scavenging activity after 1 hr by spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Jul-01, Volume: 23, Issue:13
Synthesis, antioxidant, and antimicrobial evaluation of some 2-arylbenzimidazole derivatives.
AID1904228Antiinflammatory activity in PMA-differentiated and LPS-stimulated human THP-1 cell model assessed as inhibition of NLRP3 inflammasome-driven IL-1beta production at 30 uM incubated for 24 hrs followed by LPS stimulation for 3 hrs and ATP addition for 1 hr2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome.
AID678984TP_TRANSPORTER: RT-PCR in HepG2 cells2002Toxicology, Feb-28, Volume: 171, Issue:2-3
Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression.
AID1657428Antiinflammatory activity in C57BL/6 mouse model of CS-induced pulmonary injury assessed as reduction in distinct infiltration of leukocytes in lungs at 50 mg/kg, ip for 5 days by hematoxylin and eosin staining based fluorescence microscopic analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
4β-Hydroxywithanolide E from Goldenberry (Whole Fruits of
AID773883Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells at 20 uM after 12 hrs by luciferase reporter gene assay relative to control2013Journal of medicinal chemistry, Oct-24, Volume: 56, Issue:20
3-aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as potent Nrf2/ARE inducers in human cancer cells and AOM-DSS treated mice.
AID1657425Antiinflammatory activity in C57BL/6 mouse model of CS-induced pulmonary injury assessed as reduction in hyperplasia of pneumo-cytes in lungs at 50 mg/kg, ip for 5 days by hematoxylin and eosin staining based fluorescence microscopic analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
4β-Hydroxywithanolide E from Goldenberry (Whole Fruits of
AID1301450Activation of NRF2 transcription in human HepG2C8 cells at 100 uM after 6 hrs by luciferase reporter gene assay relative to control2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Bioactive Constituents of Glycyrrhiza uralensis (Licorice): Discovery of the Effective Components of a Traditional Herbal Medicine.
AID1423560Cytoprotective activity against H2O2-induced oxidative injury in rat PC12 cells assessed as reduction in cell viability at 10 uM pretreated for 24 hrs followed by 500 uM H2O2 challenge measured after 24 hrs by MTT assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
A Steroid-Type Antioxidant Targeting the Keap1/Nrf2/ARE Signaling Pathway from the Soft Coral Dendronephthya gigantea.
AID1420760Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as induction of ARE-mediated luciferase activity at 80 uM after 24 hrs by luciferase reporter gene assay relative to control2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury.
AID755681Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Jul-01, Volume: 23, Issue:13
Synthesis, antioxidant, and antimicrobial evaluation of some 2-arylbenzimidazole derivatives.
AID1423570Inhibition of Keap1/Nrf2 signaling in rat PC12 cells assessed as induction of ARE by measuring increase in HO-1 expression at 10 uM after 24 hrs by Western blot analysis2018Journal of natural products, 11-26, Volume: 81, Issue:11
A Steroid-Type Antioxidant Targeting the Keap1/Nrf2/ARE Signaling Pathway from the Soft Coral Dendronephthya gigantea.
AID755683Antioxidant activity assessed as superoxide radical anion scavenging activity by spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Jul-01, Volume: 23, Issue:13
Synthesis, antioxidant, and antimicrobial evaluation of some 2-arylbenzimidazole derivatives.
AID659237Increase in intracellular GSH level in human MCF7 cells expressing antioxidant response element at 10 uM after 24 hrs by HPLC analysis in presence of GCL inhibitor buthionine sulfoximine2012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
A synthetic chalcone as a potent inducer of glutathione biosynthesis.
AID1657431Antiinflammatory activity in C57BL/6 mouse model of CS-induced pulmonary injury assessed as reduction in goblet cell hyperplasia in peribronchial in lungs at 50 mg/kg, ip for 5 days by hematoxylin and eosin staining based fluorescence microscopic analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
4β-Hydroxywithanolide E from Goldenberry (Whole Fruits of
AID682080TP_TRANSPORTER: Northern blot from MCF-7 cells2001Toxicology letters, Mar-31, Volume: 120, Issue:1-3
Up-regulation of transporters of the MRP family by drugs and toxins.
AID1400568Activation of Nrf2 in human BEAS2B cells assessed as upregulation of Nrf2 protein expression at 20 uM after 12 hrs by immunoblot analysis2018Bioorganic & medicinal chemistry, 10-01, Volume: 26, Issue:18
Discovery of natural flavonoids as activators of Nrf2-mediated defense system: Structure-activity relationship and inhibition of intracellular oxidative insults.
AID1439605Cytoprotective activity against H2O2-induced oxidative damage in rat PC12 cells assessed as necrotic cells at 10 uM preincubated for 24 hrs followed by H2O2 addition measured after 24 hrs by annexin V-FITC/propidium iodide staining-based flow cytometric m2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Novel antioxidants' synthesis and their anti-oxidative activity through activating Nrf2 signaling pathway.
AID1466120Activation of Nrf2 in human HepG2 cells assessed as increase in HO-1 expression level at 20 uM by Western blot analysis2017European journal of medicinal chemistry, Jul-07, Volume: 134Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death.
AID1650133Inhibition of Influenza A virus H3N2 A/X-31 hemagglutinin 3 D1122N expressed in HeLa cells assessed as polykaryon formation preincubated for 15 mins and further incubated for 15 mins with acidic buffer containing compounds at pH 5.6 by giemsa staining bas2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones.
AID1193294Inhibition of tyrosinase (unknown origin)2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Effect of the tyrosinase inhibitor (S)-N-trans-feruloyloctopamine from garlic skin on tyrosinase gene expression and melanine accumulation in melanoma cells.
AID1569624Activation of Nrf2 (unknown origin) stably transfected in human HepG2-ARE-C8 cells assessed as increase in ARE-driven luciferase activity at 1 uM by luciferase reporter gene assay relative to control2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity.
AID1386604Antioxidant activity assessed as hydroxyl radical scavenging activity incubated for 10 mins in presence of salicylic acid2018Journal of natural products, 09-28, Volume: 81, Issue:9
Hexaricins, Pradimicin-like Polyketides from a Marine Sediment-Derived Streptosporangium sp. and Their Antioxidant Effects.
AID1306866Activation of Nrf2 in human HepG2 cells at 80 uM incubated for 12 hrs by ARE-driven luciferase reporter gene assay relative to control2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core.
AID1807305Induction of Nrf2 protein level in OGD/R-induced rat primary cortical neuron pretreated at 1.8 uM for 24 hrs followed by subjected to OGD for 2 hrs measured after 24 hrs under normoxic condition by Western blot analysis
AID1904221Activation of Nrf2-ARE pathway in human HepG2-ARE-C8 cells assessed as fold upregulation of ARE-inducing luciferase activity at 80 uM measured after 24 hrs by luciferase reporter gene assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome.
AID1265003Antioxidant activity assessed as DPPH radical scavenging activity2015European journal of medicinal chemistry, Dec-01, Volume: 106Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model.
AID1306853Cytoprotective activity against H2O2-induced cytotoxicity in rat PC12 cells assessed as cell viability pretreated at 20 uM for 24 hrs followed by H2O2 challenge for 12 hrs by MTT assay (Rvb = 50%)2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core.
AID773887Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells at 5 uM after 12 hrs by luciferase reporter gene assay relative to control2013Journal of medicinal chemistry, Oct-24, Volume: 56, Issue:20
3-aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as potent Nrf2/ARE inducers in human cancer cells and AOM-DSS treated mice.
AID755679Antioxidant activity assessed as ferric ion reducing ability after 20 mins by spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Jul-01, Volume: 23, Issue:13
Synthesis, antioxidant, and antimicrobial evaluation of some 2-arylbenzimidazole derivatives.
AID1657434Antiinflammatory activity in C57BL/6 mouse model of CS-induced pulmonary injury assessed as reduction in goblet cell hyperplasia in perivascular areas in lungs at 50 mg/kg, ip for 5 days by hematoxylin and eosin staining based fluorescence microscopic ana2020Journal of natural products, 04-24, Volume: 83, Issue:4
4β-Hydroxywithanolide E from Goldenberry (Whole Fruits of
AID1439604Cytoprotective activity against H2O2-induced oxidative damage in rat PC12 cells assessed as late apoptotic cells at 10 uM preincubated for 24 hrs followed by annexin V-FITC/propidium iodide staining-based flow cytometric method (Rvb = 10.7%)2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Novel antioxidants' synthesis and their anti-oxidative activity through activating Nrf2 signaling pathway.
AID1285392Cytotoxicity against mouse Hepa1c1c7 cells after 48 hrs by SRB assay2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID1400570Activation of Nrf2 in human BEAS2B cells assessed as upregulation of gamma-GCS protein expression at 20 uM after 12 hrs by immunoblot analysis2018Bioorganic & medicinal chemistry, 10-01, Volume: 26, Issue:18
Discovery of natural flavonoids as activators of Nrf2-mediated defense system: Structure-activity relationship and inhibition of intracellular oxidative insults.
AID1650131Inhibition of influenza H3N2 A/X-31 hemagglutinin 3 expressed in HeLa cells assessed as polykaryon formation preincubated for 15 mins and further incubated for 15 mins with acidic buffer containing compounds at pH 5.2 by giemsa staining based microscopic 2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones.
AID1466119Activation of Nrf2 in human HepG2 cells assessed as increase in Nrf2 expression level at 20 uM by Western blot analysis2017European journal of medicinal chemistry, Jul-07, Volume: 134Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death.
AID1904222Activation of Nrf2-ARE pathway in human HepG2-ARE-C8 cells assessed as fold upregulation of ARE-inducing luciferase activity at 160 uM measured after 24 hrs by luciferase reporter gene assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome.
AID1807299Neuroprotective activity against in OGD/R-induced rat cortical neuron apoptosis assessed as late apoptotic cells pretreated at 1.8 uM for 24 hrs followed by subjected to OGD for 2 hrs measured after 24 hrs under normoxic condition by PI/FITC-H staining ba
AID1348749Activation of Keap1/Nrf2 in human MCF7 cells assessed as Nrf2 stabilization at 15 uM incubated overnight by luciferase reporter gene based luminescence assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Marine Natural Product Honaucin A Attenuates Inflammation by Activating the Nrf2-ARE Pathway.
AID1647465Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as fold change at 1 uM measured after 12 hrs by luciferase reporter gene assay relative to control2020Bioorganic & medicinal chemistry letters, 01-15, Volume: 30, Issue:2
Design and evaluation of Nrf2 activators with 1,3,4-oxa/thiadiazole core as neuro-protective agents against oxidative stress in PC-12 cells.
AID1466118Activation of Nrf2 in human HepG2 cells assessed as cytoprotective activity against t-BHP-induced oxidative cell death at 20 uM incubated for 24 hrs followed by compound removal with subsequent incubation with 900 uM of t-BHP for 6 hrs by MTT assay2017European journal of medicinal chemistry, Jul-07, Volume: 134Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death.
AID1569625Activation of Nrf2 (unknown origin) stably transfected in human HepG2-ARE-C8 cells assessed as increase in ARE-driven luciferase activity at 5 uM by luciferase reporter gene assay relative to control2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity.
AID1128079Inhibition of Keap1-Nrf2 interaction in human HepG2-ARE-C8 cells assessed as activation of Nrf2-ARE luciferase activity at 5 uM after 12 hrs relative to control2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis.
AID1650132Inhibition of Influenza A virus H3N2 A/X-31 hemagglutinin 3 E572K mutant expressed in HeLa cells assessed as polykaryon formation preincubated for 15 mins and further incubated for 15 mins with acidic buffer containing compounds at pH 5.2 by giemsa staini2020Bioorganic & medicinal chemistry, 01-01, Volume: 28, Issue:1
Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones.
AID1904230Cytotoxicity against human THP-1 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome.
AID659238Increase in intracellular GSH level in human MCF7 cells expressing antioxidant response element at 10 uM after 24 hrs by HPLC analysis2012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
A synthetic chalcone as a potent inducer of glutathione biosynthesis.
AID1420761Cytotoxicity against human LO2 cells up to 160 uM after 24 hrs by MTT assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury.
AID773882Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells at 40 uM after 12 hrs by luciferase reporter gene assay relative to control2013Journal of medicinal chemistry, Oct-24, Volume: 56, Issue:20
3-aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as potent Nrf2/ARE inducers in human cancer cells and AOM-DSS treated mice.
AID1501904Antioxidant activity assessed as inhibition of ferrous chloride-induced lipid peroxidation in DHA-PA labelled SLPC large unilamellar vesicle measured over 21 mins by fluorescence assay2017Journal of natural products, 09-22, Volume: 80, Issue:9
Lipid Peroxidation and Cyclooxygenase Enzyme Inhibitory Compounds from Prangos haussknechtii.
AID1807307Induction of NQO1 mRNA transcript level in OGD/R-induced rat primary cortical neuron pretreated at 1.8 uM for 24 hrs followed by subjected to OGD for 2 hrs measured after 24 hrs under normoxic condition by RT-qPCR analysis
AID1306863Activation of Nrf2 in human HepG2 cells at 0.2 uM incubated for 12 hrs by ARE-driven luciferase reporter gene assay relative to control2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core.
AID1285394Chemoprotective index, ratio of IC50 for mouse Hepa1c1c7 cells to CD for quinone reductase activity in mouse Hepa1c1c7 cells2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID293292Antioxidant activity assessed as inhibition of lipid peroxidation at 2 g/L after 2 hrs by beta carotene bleaching method2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Synthesis and antioxidant activity evaluation of new 7-aryl or 7-heteroarylamino-2,3-dimethylbenzo[b]thiophenes obtained by Buchwald-Hartwig C-N cross-coupling.
AID679993TP_TRANSPORTER: Western blot, MCF-7 cells2001Toxicology letters, Mar-31, Volume: 120, Issue:1-3
Up-regulation of transporters of the MRP family by drugs and toxins.
AID1401195Induction of Nrf2 translocation in nucleus of rat PC12 cells at 5 uM after 6 hrs by DAPI staining-based fluorescence microscopic method2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis, and evaluation of NDGA analogues as potential anti-ischemic stroke agents.
AID1904219Activation of Nrf2-ARE pathway in human HepG2-ARE-C8 cells assessed as fold upregulation of ARE-inducing luciferase activity at 20 uM measured after 24 hrs by luciferase reporter gene assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome.
AID1386605Antioxidant activity assessed as superoxide anion radical scavenging activity incubated for 20 mins measured every 30 secs for 5 mins in presence of pyrogallol2018Journal of natural products, 09-28, Volume: 81, Issue:9
Hexaricins, Pradimicin-like Polyketides from a Marine Sediment-Derived Streptosporangium sp. and Their Antioxidant Effects.
AID1215087Activation of human PXR expressed in human HepG2 (DPX-2) cells assessed as induction of CYP3A4 after 24 hrs by luminescent analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Identification of clinically used drugs that activate pregnane X receptors.
AID1265018Activation of Nrf2 in human HSC3-ARE9 cells assessed as increase of ARE-mediated AKR1C1 mRNA expression at 50 uM after 24 hrs by RT-PCR analysis relative to control2015European journal of medicinal chemistry, Dec-01, Volume: 106Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model.
AID1807300Neuroprotective activity against in OGD/R-induced rat cortical neuron apoptosis assessed as necrotic cells pretreated at 1.8 uM for 24 hrs followed by subjected to OGD for 2 hrs measured after 24 hrs under normoxic condition by PI/FITC-H staining based fl
AID1306864Activation of Nrf2 in human HepG2 cells at 2 uM incubated for 12 hrs by ARE-driven luciferase reporter gene assay relative to control2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core.
AID1285398Ratio of induction of quinone reductase specific activity in mouse mutant BpRc1 cells to mouse Hepa1c1c7 cells2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID1420764Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as induction of ARE-mediated luciferase activity at 0.2 uM after 24 hrs by luciferase reporter gene assay relative to control2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury.
AID762112Induction of Nrf2/Keap1 in human HCT116 cells assessed as induction of ARE activity at 80 uM after 12 hrs by luciferase reporter gene assay relative to control2013European journal of medicinal chemistry, Aug, Volume: 66Synthesis and bioevaluation of a series of α-pyrone derivatives as potent activators of Nrf2/ARE pathway (part I).
AID1265021Activation of Nrf2 in human HSC3-ARE9 cells assessed as increase of ARE-mediated GCLC mRNA expression at 50 uM after 24 hrs by RT-PCR analysis relative to control2015European journal of medicinal chemistry, Dec-01, Volume: 106Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model.
AID1878035Agonist activity at Nrf2 (unknown origin) at 10 uM by dual-luciferase reporter gene assay2022Bioorganic & medicinal chemistry letters, 04-01, Volume: 61Design and synthesis of Osthole-based compounds as potential Nrf2 agonists.
AID1306846Cytotoxicity against human NCM460 cells assessed as cell viability at low to medium concentration after 24 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core.
AID1889599Cytotoxicity against human HEK293-ARE-Luc cells assessed as change in cell viability incubated for 24 hrs by MTT assay2022Journal of natural products, 03-25, Volume: 85, Issue:3
Discovery, Synthesis, and Biological Evaluation of Anaenamides C and D from a New Marine Cyanobacterium,
AID744356Activation of Nrf2/ARE in E15 stage mouse primary cortical neurons at 6.25 to 50 uM after 48 hrs by human placental alkaline phosphatase reporter gene assay2013Bioorganic & medicinal chemistry, May-01, Volume: 21, Issue:9
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway.
AID1904220Activation of Nrf2-ARE pathway in human HepG2-ARE-C8 cells assessed as fold upregulation of ARE-inducing luciferase activity at 40 uM measured after 24 hrs by luciferase reporter gene assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome.
AID1647469Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as fold change at 80 uM measured after 12 hrs by luciferase reporter gene assay relative to control2020Bioorganic & medicinal chemistry letters, 01-15, Volume: 30, Issue:2
Design and evaluation of Nrf2 activators with 1,3,4-oxa/thiadiazole core as neuro-protective agents against oxidative stress in PC-12 cells.
AID1215090Activation of rat PXR expressed in human HepG2 cells after 24 hrs by luciferase reporter gene based luminescent analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Identification of clinically used drugs that activate pregnane X receptors.
AID1423565Cytoprotective activity against H2O2-induced oxidative injury in rat PC12 cells assessed as inhibition of MDA production at 10 uM pretreated for 24 hrs followed by H2O2 challenge measured after 16 hrs2018Journal of natural products, 11-26, Volume: 81, Issue:11
A Steroid-Type Antioxidant Targeting the Keap1/Nrf2/ARE Signaling Pathway from the Soft Coral Dendronephthya gigantea.
AID1285397Chemoprotective index, ratio of IC50 for mouse mutant BpRc1 cells to CD for quinone reductase activity in mouse mutant BpRc1 cells2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID1647464Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as fold change at 0.1 uM measured after 12 hrs by luciferase reporter gene assay relative to control2020Bioorganic & medicinal chemistry letters, 01-15, Volume: 30, Issue:2
Design and evaluation of Nrf2 activators with 1,3,4-oxa/thiadiazole core as neuro-protective agents against oxidative stress in PC-12 cells.
AID1420759Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as induction of ARE-mediated luciferase activity at 40 uM after 24 hrs by luciferase reporter gene assay relative to control2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury.
AID1128078Inhibition of Keap1-Nrf2 interaction in human HepG2-ARE-C8 cells assessed as activation of Nrf2-ARE luciferase activity at 20 uM after 12 hrs relative to control2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis.
AID1904227Antiinflammatory activity in PMA-differentiated and LPS-stimulated human THP-1 cell model assessed as inhibition of NLRP3 inflammasome-driven IL-1beta production at 15 uM incubated for 24 hrs followed by LPS stimulation for 3 hrs and ATP addition for 1 hr2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome.
AID1686267Activation of NRF2 in human MCF-7/AREc32 cells at 3 uM incubated for 24 hrs by luciferase reporter gene assay2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
AID1647468Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as fold change at 40 uM measured after 12 hrs by luciferase reporter gene assay relative to control2020Bioorganic & medicinal chemistry letters, 01-15, Volume: 30, Issue:2
Design and evaluation of Nrf2 activators with 1,3,4-oxa/thiadiazole core as neuro-protective agents against oxidative stress in PC-12 cells.
AID1306852Cytoprotective activity against H2O2-induced cytotoxicity in human NCM460 cells assessed as cell viability pretreated at 20 uM for 24 hrs followed by H2O2 challenge for 12 hrs by MTT assay (Rvb = 50%)2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core.
AID1306851Cytoprotective activity against H2O2-induced cytotoxicity in human L02 cells assessed as cell viability pretreated at 20 uM for 24 hrs followed by H2O2 challenge for 12 hrs by MTT assay (Rvb = 50%)2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core.
AID1306862Activation of Nrf2 in human HepG2 cells at 0.02 uM incubated for 12 hrs by ARE-driven luciferase reporter gene assay relative to control2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core.
AID1807297Neuroprotective activity against in OGD/R-induced rat primary cortical neuron apoptosis assessed as viable cells pretreated at 1.8 uM for 24 hrs followed by subjected to OGD for 2 hrs measured after 24 hrs under normoxic condition by PI/FITC-H staining ba
AID1285399Induction of Nrf2 nuclear translocation in mouse Hepa1c1c7 cells assessed as protein accumulation in nucleus at 20 uM by DAPI staining based immunofluorescence assay2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID1400569Activation of Nrf2 in human BEAS2B cells assessed as upregulation of NQO1 protein expression at 20 uM after 12 hrs by immunoblot analysis2018Bioorganic & medicinal chemistry, 10-01, Volume: 26, Issue:18
Discovery of natural flavonoids as activators of Nrf2-mediated defense system: Structure-activity relationship and inhibition of intracellular oxidative insults.
AID1265006Activation of Nrf2 in human HSC3-ARE9 cells assessed as increase of ARE-mediated Prx1 mRNA expression at 50 uM after 24 hrs by RT-PCR analysis relative to control2015European journal of medicinal chemistry, Dec-01, Volume: 106Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model.
AID1306865Activation of Nrf2 in human HepG2 cells at 40 uM incubated for 12 hrs by ARE-driven luciferase reporter gene assay relative to control2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core.
AID1686269Activation of NRF2 in human MCF-7/AREc32 cells assessed as concentration required to double Nrf2 transcriptional pathway by measuring specific luciferase reporter activity incubated for 24 hrs by luciferase reporter gene assay2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
AID1420758Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as induction of ARE-mediated luciferase activity at 20 uM after 24 hrs by luciferase reporter gene assay relative to control2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury.
AID718463Antioxidant activity in human U373 cells assessed as increase of antioxidant response element-mediated phase 2 protein expression at 25 ug/ml after 24 hrs by luciferase reporter gene assay relative to control2012Journal of natural products, Dec-28, Volume: 75, Issue:12
Isolation of steroidal glycosides from the Caribbean sponge Pandaros acanthifolium.
AID1285396Induction of quinone reductase activity in mouse mutant BpRc1 cells using 2,6-DCIP as substrate measured for 1 min2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID1657441Antiinflammatory activity in C57BL/6 mouse model of CS-induced pulmonary injury assessed as reduction in 8-oxo-dG in lungs at 50 mg/kg, ip for 5 days by ELISA2020Journal of natural products, 04-24, Volume: 83, Issue:4
4β-Hydroxywithanolide E from Goldenberry (Whole Fruits of
AID1807298Neuroprotective activity against in OGD/R-induced rat cortical neuron apoptosis assessed as early apoptotic cells pretreated at 1.8 uM for 24 hrs followed by subjected to OGD for 2 hrs measured after 24 hrs under normoxic condition by PI/FITC-H staining b
AID1465325Inhibition of Keap1-Nrf2 protein-protein interaction in MEF assessed as increase in Nrf2 activation mediated NQO1 mRNA level at 10 uM after 4 hrs by qRT-PCR method2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Discovery of benzo[g]indoles as a novel class of non-covalent Keap1-Nrf2 protein-protein interaction inhibitor.
AID1306867Activation of Nrf2 in human HepG2 cells at 160 uM incubated for 12 hrs by ARE-driven luciferase reporter gene assay relative to control2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core.
AID1285395Cytotoxicity against mouse mutant BpRc1 cells after 48 hrs by SRB assay2016Bioorganic & medicinal chemistry, Apr-15, Volume: 24, Issue:8
In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
AID1386603Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins by UV/visible spectrophotometric analysis2018Journal of natural products, 09-28, Volume: 81, Issue:9
Hexaricins, Pradimicin-like Polyketides from a Marine Sediment-Derived Streptosporangium sp. and Their Antioxidant Effects.
AID1608142Activation of Nrf2 (unknown origin) expressed in HEK293 cells co-transfected with ARE luciferase reporter plasmid at 20 uM after 16 hrs by dual luciferase reporter gene assay2019European journal of medicinal chemistry, Oct-15, Volume: 180Synthesis and assessment of phenylacrylamide derivatives as potential anti-oxidant and anti-inflammatory agents.
AID1807306Induction of HO-1 mRNA transcript level in OGD/R-induced rat primary cortical neuron pretreated at 1.8 uM for 24 hrs followed by subjected to OGD for 2 hrs measured after 24 hrs under normoxic condition by RT-qPCR analysis
AID1231465Activation of Nrf2 in human NPC-TW01 or HONE1 cells expressing ARE-luciferase at 20 uM incubated for 16 hrs by luciferase reporter gene assay relative to untreated control2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Discovery of oxime-bearing naphthalene derivatives as a novel structural type of Nrf2 activators.
AID1904229Antiinflammatory activity in PMA-differentiated and LPS-stimulated human THP-1 cell model assessed as inhibition of NLRP3 inflammasome-driven IL-1beta production at 45 uM incubated for 24 hrs followed by LPS stimulation for 3 hrs and ATP addition for 1 hr2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome.
AID773886Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells at 10 uM after 12 hrs by luciferase reporter gene assay relative to control2013Journal of medicinal chemistry, Oct-24, Volume: 56, Issue:20
3-aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as potent Nrf2/ARE inducers in human cancer cells and AOM-DSS treated mice.
AID1128082Inhibition of Keap1-Nrf2 interaction in human HepG2-ARE-C8 cells assessed as activation of Nrf2-ARE luciferase activity at 80 uM after 12 hrs relative to control2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis.
AID1569623Activation of Nrf2 (unknown origin) stably transfected in human HepG2-ARE-C8 cells assessed as increase in ARE-driven luciferase activity at 0.1 uM by luciferase reporter gene assay relative to control2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity.
AID1420763Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as induction of ARE-mediated luciferase activity at 0.02 uM after 24 hrs by luciferase reporter gene assay relative to control2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury.
AID1128080Inhibition of Keap1-Nrf2 interaction in human HepG2-ARE-C8 cells assessed as activation of Nrf2-ARE luciferase activity at 10 uM after 12 hrs relative to control2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis.
AID773885Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells after 12 hrs by luciferase reporter gene assay2013Journal of medicinal chemistry, Oct-24, Volume: 56, Issue:20
3-aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as potent Nrf2/ARE inducers in human cancer cells and AOM-DSS treated mice.
AID1569627Activation of Nrf2 (unknown origin) stably transfected in human HepG2-ARE-C8 cells assessed as increase in ARE-driven luciferase activity at 20 uM by luciferase reporter gene assay relative to control2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity.
AID1569622Activation of Nrf2 (unknown origin) stably transfected in human HepG2-ARE-C8 cells assessed as increase in ARE-driven luciferase activity at 0.01 uM by luciferase reporter gene assay relative to control2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity.
AID1904218Activation of Nrf2-ARE pathway in human HepG2-ARE-C8 cells assessed as fold upregulation of ARE-inducing luciferase activity at 10 uM measured after 24 hrs by luciferase reporter gene assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome.
AID377968Antioxidant activity against Fe2+-induced lipid peroxidation at 20 uM by fluorescence spectroscopy1999Journal of natural products, Jan, Volume: 62, Issue:1
Novel antioxidant compounds from tart cherries (Prunus cerasus).
AID1423567Cytoprotective activity against H2O2-induced oxidative injury in rat PC12 cells assessed as reduction in intracellular reactive oxygen species formation at 10 uM pretreated for 24 hrs followed by H2O2 challenge measured after 3 hrs by DCFH-DA dye based fl2018Journal of natural products, 11-26, Volume: 81, Issue:11
A Steroid-Type Antioxidant Targeting the Keap1/Nrf2/ARE Signaling Pathway from the Soft Coral Dendronephthya gigantea.
AID1439603Cytoprotective activity against H2O2-induced oxidative damage in rat PC12 cells assessed as early apoptotic cells at 10 uM preincubated for 24 hrs followed by H2O2 addition measured after 24 hrs by annexin V-FITC/propidium iodide staining-based flow cytom2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Novel antioxidants' synthesis and their anti-oxidative activity through activating Nrf2 signaling pathway.
AID1484039Activation of Nrf2 (unknown origin) expressed in human HepG2 cells at 10 uM after 6 hrs by ARE-driven luciferase reporter gene assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID1128081Inhibition of Keap1-Nrf2 interaction in human HepG2-ARE-C8 cells assessed as activation of Nrf2-ARE luciferase activity at 40 uM after 12 hrs relative to control2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis.
AID1439606Cytoprotective activity against H2O2-induced oxidative damage in rat PC12 cells assessed as viable cells at 10 uM preincubated for 24 hrs followed by H2O2 addition measured after 24 hrs by annexin V-FITC/propidium iodide staining-based flow cytometric met2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Novel antioxidants' synthesis and their anti-oxidative activity through activating Nrf2 signaling pathway.
AID1569626Activation of Nrf2 (unknown origin) stably transfected in human HepG2-ARE-C8 cells assessed as increase in ARE-driven luciferase activity at 10 uM by luciferase reporter gene assay relative to control2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity.
AID678983TP_TRANSPORTER: Western blot, HepG2 cells2002Toxicology, Feb-28, Volume: 171, Issue:2-3
Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression.
AID1657422Antiinflammatory activity in C57BL/6 mouse model of CS-induced pulmonary injury assessed as reduction in thickening of the alveolar septa in lungs at 50 mg/kg, ip for 5 days by hematoxylin and eosin staining based fluorescence microscopic analysis2020Journal of natural products, 04-24, Volume: 83, Issue:4
4β-Hydroxywithanolide E from Goldenberry (Whole Fruits of
AID1420765Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as induction of ARE-mediated luciferase activity at 2 uM after 24 hrs by luciferase reporter gene assay relative to control2018European journal of medicinal chemistry, Sep-05, Volume: 157Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury.
AID1265014Activation of Nrf2 in human HSC3-ARE9 cells assessed as increase of ARE-mediated luciferase expression at 50 uM after 24 hrs relative to control2015European journal of medicinal chemistry, Dec-01, Volume: 106Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model.
AID1301449Activation of NRF2 transcription in human HepG2C8 cells at 10 uM after 6 hrs by luciferase reporter gene assay relative to control2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Bioactive Constituents of Glycyrrhiza uralensis (Licorice): Discovery of the Effective Components of a Traditional Herbal Medicine.
AID1466121Activation of Nrf2 in human HepG2 cells assessed as increase in GCLC expression level at 20 uM by Western blot analysis2017European journal of medicinal chemistry, Jul-07, Volume: 134Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death.
AID1401197Induction of Nrf2 translocation in nucleus of rat PC12 cells assessed as upregulation of HO-1 protein expression at 10 uM after 24 hrs by Western blot method2018European journal of medicinal chemistry, Jan-01, Volume: 143Design, synthesis, and evaluation of NDGA analogues as potential anti-ischemic stroke agents.
AID1647466Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as fold change at 10 uM measured after 12 hrs by luciferase reporter gene assay relative to control2020Bioorganic & medicinal chemistry letters, 01-15, Volume: 30, Issue:2
Design and evaluation of Nrf2 activators with 1,3,4-oxa/thiadiazole core as neuro-protective agents against oxidative stress in PC-12 cells.
AID1686268Activation of NRF2 in human MCF-7/AREc32 cells at 10 to 30 uM incubated for 24 hrs by luciferase reporter gene assay2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
AID376415Antioxidation activity assessed as inhibition of peroxidation of liposome at 1.66 ug/mL1999Journal of natural products, Nov, Volume: 62, Issue:11
Phenolic glycosides from Dirca palustris.
AID1348750Cytotoxicity against human MCF7 cells assessed as decrease in cell viability at 15 uM by MTT assay2018Journal of natural products, 03-23, Volume: 81, Issue:3
Marine Natural Product Honaucin A Attenuates Inflammation by Activating the Nrf2-ARE Pathway.
AID1215086Activation of human PXR expressed in human HepG2 (DPX-2) cells after 24 hrs by luciferase reporter gene based luminescent analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Identification of clinically used drugs that activate pregnane X receptors.
AID602813Inhibition of Sarcoplasmic/endoplasmic reticulum calcium ATPase in rabbit hind leg tissue microsomes assessed as rate of NADH oxidation coupled to SERCA-catalyzed ATP hydrolysis at <100 uM by spectroscopic assay2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Discovery of novel SERCA inhibitors by virtual screening of a large compound library.
AID1306847Cytotoxicity against rat PC12 cells assessed as cell viability at low to medium concentration after 24 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core.
AID1423562Cytoprotective activity against H2O2-induced oxidative injury in rat PC12 cells assessed as increase in colony formation at 5 uM pretreated for 24 hrs followed by H2O2 challenge by crystal violet staining based assay2018Journal of natural products, 11-26, Volume: 81, Issue:11
A Steroid-Type Antioxidant Targeting the Keap1/Nrf2/ARE Signaling Pathway from the Soft Coral Dendronephthya gigantea.
AID1306845Cytotoxicity against human L02 cells assessed as cell viability at low to medium concentration after 24 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core.
AID762110Cytotoxicity against human HCT116 cells by MTT assay2013European journal of medicinal chemistry, Aug, Volume: 66Synthesis and bioevaluation of a series of α-pyrone derivatives as potent activators of Nrf2/ARE pathway (part I).
AID1889601Activation of Nrf2 in human HEK293-ARE-Luc cells assessed as fold activation of luciferase activity at 32 uM incubated for 24 hrs by ARE-luciferase reporter gene assay2022Journal of natural products, 03-25, Volume: 85, Issue:3
Discovery, Synthesis, and Biological Evaluation of Anaenamides C and D from a New Marine Cyanobacterium,
AID1807304Effect on Nrf2 mRNA transcript level in OGD/R-induced rat primary cortical neuron pretreated at 1.8 uM for 24 hrs followed by subjected to OGD for 2 hrs measured after 24 hrs under normoxic condition by RT-qPCR analysis
AID1647467Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as fold change at 20 uM measured after 12 hrs by luciferase reporter gene assay relative to control2020Bioorganic & medicinal chemistry letters, 01-15, Volume: 30, Issue:2
Design and evaluation of Nrf2 activators with 1,3,4-oxa/thiadiazole core as neuro-protective agents against oxidative stress in PC-12 cells.
AID1501903Antioxidant activity assessed as redox reaction between compound and MTT in DMSO measured after 6 hrs2017Journal of natural products, 09-22, Volume: 80, Issue:9
Lipid Peroxidation and Cyclooxygenase Enzyme Inhibitory Compounds from Prangos haussknechtii.
AID1738629Neuroprotective activity against H2O2-induced cytotoxicity in rat PC-12 cells assessed as cell viability at 12.5 uM pretreated for 24 hrs followed by H2O2 challenge and measured after 24 hrs by MTT assay (Rvb = 52.81 +/- 6%)2020European journal of medicinal chemistry, Aug-01, Volume: 199Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/keap1 pathway.
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID773881Induction of Nrf2-mediated ARE activity in human HepG2-ARE-C8 cells at 80 uM after 12 hrs by luciferase reporter gene assay relative to control2013Journal of medicinal chemistry, Oct-24, Volume: 56, Issue:20
3-aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as potent Nrf2/ARE inducers in human cancer cells and AOM-DSS treated mice.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (614)

TimeframeStudies, This Drug (%)All Drugs %
pre-199027 (4.40)18.7374
1990's93 (15.15)18.2507
2000's171 (27.85)29.6817
2010's238 (38.76)24.3611
2020's85 (13.84)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.72 (24.57)
Research Supply Index6.46 (2.92)
Research Growth Index5.10 (4.65)
Search Engine Demand Index34.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.32%)5.53%
Reviews9 (1.42%)6.00%
Case Studies7 (1.11%)4.05%
Observational0 (0.00%)0.25%
Other615 (97.16%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]